FSVLX
Price
$17.80
Change
+$1.73 (+10.77%)
Updated
Apr 9 closing price
Net Assets
106.08M
TFIFX
Price
$38.92
Change
-$1.49 (-3.69%)
Updated
Apr 10 closing price
Net Assets
1.74B
Ad is loading...

FSVLX vs TFIFX

Header iconFSVLX vs TFIFX Comparison
Open Charts FSVLX vs TFIFXBanner chart's image
Fidelity Select Fintech Port
Price$17.80
Change+$1.73 (+10.77%)
VolumeN/A
Net Assets106.08M
T. Rowe Price Financial Services I
Price$38.92
Change-$1.49 (-3.69%)
VolumeN/A
Net Assets1.74B
FSVLX vs TFIFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSVLX vs. TFIFX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSVLX is a Buy and TFIFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
TFIFX has more cash in the bank: 1.75B vs. FSVLX (106M). TFIFX pays higher dividends than FSVLX: TFIFX (1.23) vs FSVLX (0.00). FSVLX was incepted earlier than TFIFX: FSVLX (39 years) vs TFIFX (8 years). TFIFX (0.82) is less costly to investors than FSVLX (0.76). TFIFX is a more actively managed with annual turnover of: 46.90 vs. FSVLX (43.00). FSVLX has a lower initial minimum investment than TFIFX: FSVLX (0) vs TFIFX (500000). TFIFX annual gain was more profitable for investors over the last year : -2.79 vs. FSVLX (-6.08). TFIFX return over 5 years is better than : 89.91 vs. FSVLX (42.78).
FSVLXTFIFXFSVLX / TFIFX
Total Expense Ratio0.760.7996%
Annual Report Gross Expense Ratio0.760.8293%
Fund Existence39 years8 years-
Gain YTD-17.079-11.971143%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets106M1.75B6%
Annual Yield % from dividends0.001.23-
Returns for 1 year-6.08-2.79218%
Returns for 3 years1.5815.3910%
Returns for 5 years42.7889.9148%
Returns for 10 years25.78N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNA6.781.02
+17.71%
Ginkgo Bioworks Holdings
VRTS159.8813.01
+8.86%
Virtus Investment Partners
SYK362.9725.60
+7.59%
Stryker Corp
MDGL313.9511.17
+3.69%
Madrigal Pharmaceuticals
MCHX1.32-0.05
-3.65%
Marchex